Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Quality of life for children and families affected by neurological disorders.

Parker AP.

Eur J Paediatr Neurol. 2019 Nov;23(6):762. doi: 10.1016/j.ejpn.2019.10.003. Epub 2019 Oct 29. No abstract available.

PMID:
31690533
2.

Fifteen-minute consultation: Efficient investigation of the child with early developmental impairment in the era of genomic sequencing.

Coysh T, Hogg SL, Parker AP.

Arch Dis Child Educ Pract Ed. 2019 May 15. pii: edpract-2018-315123. doi: 10.1136/archdischild-2018-315123. [Epub ahead of print] Review.

PMID:
31092397
3.

PEHO syndrome: the endpoint of different genetic epilepsies.

Chitre M, Nahorski MS, Stouffer K, Dunning-Davies B, Houston H, Wakeling EL, Brady AF, Zuberi SM, Suri M, Parker APJ, Woods CG.

J Med Genet. 2018 Dec;55(12):803-813. doi: 10.1136/jmedgenet-2018-105288. Epub 2018 Oct 4.

PMID:
30287594
4.

Genome annotation for clinical genomic diagnostics: strengths and weaknesses.

Steward CA, Parker APJ, Minassian BA, Sisodiya SM, Frankish A, Harrow J.

Genome Med. 2017 May 30;9(1):49. doi: 10.1186/s13073-017-0441-1. Review.

5.

Outcome and recurrence 1 year after pediatric arterial ischemic stroke in a population-based cohort.

Mallick AA, Ganesan V, Kirkham FJ, Fallon P, Hedderly T, McShane T, Parker AP, Wassmer E, Wraige E, Amin S, Edwards HB, Cortina-Borja M, O'Callaghan FJ.

Ann Neurol. 2016 May;79(5):784-793. doi: 10.1002/ana.24626. Epub 2016 Apr 5.

PMID:
26928665
6.

Annual review of children with neurofibromatosis type 1.

Dunning-Davies BM, Parker AP.

Arch Dis Child Educ Pract Ed. 2016 Apr;101(2):102-11. doi: 10.1136/archdischild-2014-308084. Epub 2015 Oct 20. Review.

PMID:
26486853
7.

Lexical use in emotional autobiographical narratives of persons with schizophrenia and healthy controls.

Hong K, Nenkova A, March ME, Parker AP, Verma R, Kohler CG.

Psychiatry Res. 2015 Jan 30;225(1-2):40-49. doi: 10.1016/j.psychres.2014.10.002. Epub 2014 Dec 3.

PMID:
25480546
8.

Diagnostic delays in paediatric stroke.

Mallick AA, Ganesan V, Kirkham FJ, Fallon P, Hedderly T, McShane T, Parker AP, Wassmer E, Wraige E, Amin S, Edwards HB, O'Callaghan FJ.

J Neurol Neurosurg Psychiatry. 2015 Aug;86(8):917-21. doi: 10.1136/jnnp-2014-309188. Epub 2014 Oct 23.

PMID:
25342203
9.

Childhood arterial ischaemic stroke incidence, presenting features, and risk factors: a prospective population-based study.

Mallick AA, Ganesan V, Kirkham FJ, Fallon P, Hedderly T, McShane T, Parker AP, Wassmer E, Wraige E, Amin S, Edwards HB, Tilling K, O'Callaghan FJ.

Lancet Neurol. 2014 Jan;13(1):35-43. doi: 10.1016/S1474-4422(13)70290-4. Epub 2013 Dec 2.

PMID:
24304598
10.

A physical and chemical comparison of material from a conventional spray-dried system and a single particle spray-dried system.

Whiteside PT, Zhang J, Parker AP, Madden-Smith CE, Patel N, Jensen J, Sloth J, Roberts CJ.

Int J Pharm. 2013 Oct 15;455(1-2):306-11. doi: 10.1016/j.ijpharm.2013.07.013. Epub 2013 Jul 16.

PMID:
23872224
11.

Abnormal cerebrospinal fluid biochemistry in biotinidase deficiency causing diagnostic conundrum.

Krishnakumar D, Maw A, Brown R, Hogg S, Calvin J, Parker AP.

J Child Neurol. 2014 Jan;29(1):93-5. doi: 10.1177/0883073812467507. Epub 2012 Dec 6.

PMID:
23220796
12.

Nanoscale thermal analysis of pharmaceutical solid dispersions.

Zhang J, Bunker M, Chen X, Parker AP, Patel N, Roberts CJ.

Int J Pharm. 2009 Oct 1;380(1-2):170-3. doi: 10.1016/j.ijpharm.2009.07.003. Epub 2009 Jul 9.

PMID:
19596429
13.

Investigation into potential mechanisms promoting biocompatibility of polymeric biomaterials containing the phosphorylcholine moiety. A physicochemical and biological study.

Parker AP, Reynolds PA, Lewis AL, Kirkwood L, Hughes LG.

Colloids Surf B Biointerfaces. 2005 Dec 30;46(4):204-17. Epub 2005 Dec 7.

PMID:
16337779
14.

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Panayiotopoulos CP, Benbadis SR, Covanis A, Dulac O, Duncan JS, Eeg-Olofsson O, Ferrie CD, Grünewald RA, Kasteleijn-Nolst Trenité DG, Koutroumanidis M, Martinovic Z, Newton RW, Parker AP, Salas-Puig J, Sander JW, Shorvon S, Watanabe K, Whitehouse WP, Youroukos S.

Neurology. 2005 Jan 11;64(1):172-4; author reply 172-4. No abstract available.

PMID:
15645539
15.

Efficacy and tolerability of the new antiepileptic drugs: commentary on the recently published practice parameters.

Panayiotopoulos CP, Benbadis SR, Covanis A, Dulac O, Duncan JS, Eeg-Olofsson O, Ferrie CD, Grünewald RA, Kasteleijn-Nolst Trenite DG, Koutroumanidis M, Martinovic Z, Newton RW, Parker AP, Salas-Puig J, Sander JW, Shorvon S, Watanabe K, Whitehouse WP, Youroukos S.

Epilepsia. 2004 Dec;45(12):1646-9; author reply 1649-51. No abstract available.

16.

Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.

Weldon CB, Parker AP, Patten D, Elliott S, Tang Y, Frigo DE, Dugan CM, Coakley EL, Butler NN, Clayton JL, Alam J, Curiel TJ, Beckman BS, Jaffe BM, Burow ME.

Int J Oncol. 2004 Jun;24(6):1473-80.

PMID:
15138590
17.

Vagal nerve stimulation in the epileptic encephalopathies: 3-year follow-up.

Parker AP, Polkey CE, Robinson RO.

Pediatrics. 2001 Jul;108(1):221. No abstract available.

PMID:
11452969
18.

Vagal nerve stimulation in epileptic encephalopathies.

Parker AP, Polkey CE, Binnie CD, Madigan C, Ferrie CD, Robinson RO.

Pediatrics. 1999 Apr;103(4 Pt 1):778-82.

PMID:
10103302
19.

Neuroimaging and spectroscopy in children with epileptic encephalopathies.

Parker AP, Ferrie CD, Keevil S, Newbold M, Cox T, Maisey M, Robinson RO.

Arch Dis Child. 1998 Jul;79(1):39-43.

20.

Inappropriate use of carbamazepine and vigabatrin in typical absence seizures.

Parker AP, Agathonikou A, Robinson RO, Panayiotopoulos CP.

Dev Med Child Neurol. 1998 Aug;40(8):517-9.

21.

An aggressive seizure and behavioural disorder following trivial head injury.

Parker AP, Agathonikou A, Panayiotopoulos CP.

Seizure. 1997 Dec;6(6):499-501.

22.

Vigabatrin aggravates absences and absence status.

Panayiotopoulos CP, Agathonikou A, Sharoqi IA, Parker AP.

Neurology. 1997 Nov;49(5):1467. No abstract available.

PMID:
9371946
23.

Difficulties in diagnosing intrinsic spinal cord tumours.

Parker AP, Robinson RO, Bullock P.

Arch Dis Child. 1996 Sep;75(3):204-7.

24.
25.

Evaluation of the suitability of butadiene-acrylonitrile rubbers as closures for parenteral solutions.

Shanker J, Gibaldi M, Kanig JL, Parker AP, Lachman L.

J Pharm Sci. 1967 Jan;56(1):100-8. No abstract available.

PMID:
6030479
26.

DISSOLUTION KINETICS OF A WEAK ACID, 1,1-HEXAMETHYLENE P-TOLYLSULFONYLSEMICARBAZIDE, AND ITS SODIUM SALT.

HIGUCHI WI, PARKER AP, HAMLIN WE.

J Pharm Sci. 1965 Jan;54:8-11. No abstract available.

PMID:
14288503
27.

Emergency appendectomy in a patient receiving anticoagulants for myocardial infarction.

VANDER VEER JB, PARKER AP, BOYER FR.

J Am Med Assoc. 1952 Aug 2;119(14):1307-8. No abstract available.

PMID:
14938168

Supplemental Content

Loading ...
Support Center